Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06737068 · ClinicalTrials.gov registry record · NA
Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair
A NA study, sponsored by Riverside University Health System Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT06737068: Clinical Trial NA study, sponsored by Riverside University Health System Medical Center.
NCT06737068 is a NA study that has not yet begun recruiting, run by Riverside University Health System Medical Center. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06737068, a NA study, has not yet begun recruiting, sponsored by Riverside University Health System Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the incidence and severity of post-operative shoulder pain following elective robot-assisted hiatal hernia repair in hopes of reducing pain and associated costs as well as clinic and emergency department visits due to this pain. You will undergo standard robot-assisted hiatal hernia repair with the standard postoperative care. The only difference is that you may be selected for the group where lower pressures used to fill your abdomen with carbon dioxide will be used, and you will be asked to fill out logs regarding your pain postoperatively. You will have postoperative appointments that are standard following this procedure.
Primary Outcome
Percentage reduction in post-operative shoulder pain from POD#0 to \~1 week post-operative telephone appointment
Interventions
- PROCEDURE Low pressure pneumoperitoneum (8-10mmHg) with AirSeal device
- PROCEDURE Standard pressure pneumoperitoneum (13- 15 mmHg) with AirSeal device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-01-01 |
| Est. Completion | 2027-01 |
| Phase | NA |
What is known before NCT06737068 opens enrollment
NCT06737068 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which Low pressure pneumoperitoneum (8-10mmHg) with AirSeal device is the first listed.
NCT06737068 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06737068 about?
NCT06737068 is a clinical study titled "Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair". The goal of this clinical trial is to evaluate the incidence and severity of post-operative shoulder pain following elective robot-assisted hiatal hernia repair in hopes of reducing pain and associated costs as well as clinic and emergency department visits due to this pain. You will undergo standar...
What is the current status of trial NCT06737068?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-01-01. Estimated completion is 2027-01.
What interventions are being tested in trial NCT06737068?
The interventions under investigation include: Low pressure pneumoperitoneum (8-10mmHg) with AirSeal device (PROCEDURE), Standard pressure pneumoperitoneum (13- 15 mmHg) with AirSeal device (PROCEDURE).
Who is sponsoring clinical trial NCT06737068?
This trial is sponsored by Riverside University Health System Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06737068's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI